Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Return on Assets [ROA] (2020 - 2026)

Updated

Nurix Therapeutics' Return on Assets [ROA] came in at 34.08% for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 78.02 percentage points from -43.95% a year earlier and up 92.34 percentage points from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Return on Assets [ROA] was -38.96%, down 1.19 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -19.32 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Assets [ROA] was -37.77% in FY2024 (-0.50 pp), -37.27% in FY2023 (+3.10 pp), -40.37% in FY2022 (-13.53 pp) and -26.85% in FY2021 (-7.21 pp).
  • The fiscal Q3 2026 figure represents the highest quarterly Return on Assets [ROA] in data going back to fiscal Q4 2020.
  • Year-over-year, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of +6.10 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q3 2026 (a gain of 78.02 percentage points), and the weakest in fiscal Q2 2026 (a drop of 23.90 percentage points).
  • Business Quant data shows NRIX's Return on Assets [ROA] at -58.26% (Q2 2026), -44.59% (Q1 2026) and -43.68% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 34.08%
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 34.08%
May 31, 2026 -58.26%
Feb 28, 2026 -44.59%
Nov 30, 2025 -43.68%
Aug 31, 2025 -43.95%
May 31, 2025 -34.36%
Feb 28, 2025 -32.45%
Nov 30, 2024 -32.73%
Aug 31, 2024 -34.54%
May 31, 2024 -40.06%
Feb 29, 2024 -43.32%
Nov 30, 2023 -43.37%
Aug 31, 2023 -45.14%
May 31, 2023 -43.69%
Feb 28, 2023 -45.38%
Nov 30, 2022 -41.17%
Aug 31, 2022 -40.14%
May 31, 2022 -37.13%
Feb 28, 2022 -29.62%
Nov 30, 2021 -24.16%
API Access

Nurix Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEY